Nvidia, Eli Lilly Partner for $1 Billion AI Lab to Revolutionize Drug Research

• Nvidia and Eli Lilly plan a $1 billion AI laboratory over five years to accelerate drug research.
• The facility in Silicon Valley aims to integrate Eli Lilly's operations with global AI innovation.
• The collaboration seeks to transform drug discovery by automating human-dependent physical experiments.
• Nvidia, the world's most valuable corporation, is expanding its AI market into healthcare and pharmaceuticals.
• The lab will enable AI engineers to adapt computing systems for tasks traditionally done by human researchers.

Why It Matters: Nvidia and Eli Lilly's $1 billion AI lab aims to automate and accelerate drug discovery and research.